Optimizing Patient Outcomes with Adjunctive OTC Skincare

JDD Multimedia

Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative webinar on the latest science and role of adjunctive OTC skincare in optimizing patient outcomes. Explore Hydro Boost Technologies and the latest findings on pre/post-procedure care & complementary Rx support. Discover valuable insights from the science behind Neutrogena®.

Faculty

Ted Lain, MD
Chief Medical Officer at Sanova Dermatology
Executive Director at Austin Institute for Clinical Research
Austin, Texas

Star Walsh
R&D Director at Neutrogena® Skin Health

Watch On Demand

Shots, Shots, Shots: Is There Such a Thing as One Too Many?

Mikaela Sonis | Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments

Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…

F around and Find Out: Failing Forward, IL-17F in Focus, and Finding New Treatment Paradigms and Friendships through Industry Collaborations

Mikaela Sonis | Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments

Guest: Dr. Tae Oh For too long, the therapeutic ladder in hidradenitis suppurativa has often looked less like a ladder and more like an uneven mound: try this, fail that,…

“Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care

Mikaela Sonis | Featured Articles, Latest News, Podcast, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments

Guest: Dr. Adelina Hung For decades, corticosteroids have been the gastrointestinal equivalent of duct tape: they fix almost everything, at least long enough to convince us the job is done.…